- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Manufacturing
Manufacturing is the backbone of our supply chain. We continuously strive for excellence in infrastructure and technology.
The Group has Finished Dosage and API manufacturing facilities. All the facilities have requisite manufacturing capabilities to support our endeavour to provide quality products at competitive prices meeting the continuously increasing GMP requirements. The consistent and continued investments in the facilities have backed us to meet the customers' dynamic demands. Our sustainable focus on quality, safety and the most recent GMP and regulatory requirements have made us as one of the preferred suppliers worldwide.
Our manufacturing locations are regulatory approved by US-FDA, EU-GMP, TGA-Australia, WHO & PMDA-Japan.
- Experienced personnel acting globally (local presence, mother language skills).
- International pharmaceutical legislation and regulation knowledge.
- Experiences in preparation, coordination and follow-up of international authority inspections.
- Broad pharmaceutical technical expertise covering drug substance and product manufacturing aspects.
- Guideline and Regulation tracking.